Upcoming Conferences in the Life Sciences Industry

Life Sciences Baltics is the only and finest Baltics’ life sciences forum gathering global biotechnology, pharmaceutical and medical devices leaders. Forum provides a unique programme that features a variety of opportunities to get insights and seek process of life sciences through the conference, plenary and educational sessions, potential one-on-one meetings and scientific posters area. Discover Lithuania and the Baltics as a potential gateway to emerging markets in a global life sciences’ landscape.

BioPharm America™ is a unique partnering event that forms the nexus of discovery and realization. Startup companies, established biotech and entrepreneurs from academia attend in search of finance, pharma and development partners. The event format highlights innovation and promotes new business relationships by bringing dealmakers from the life science ecosystem together to engage and de-risk the enormous task of drug development. Life science executives from around the world gather to identify, meet and to enter into strategic relationships facilitated by partneringONE®, the world’s leading web-based partnering system. BioPharm America is the only event in North America based on the same reputable formula as EBD Group’s acclaimed European events BIO-Europe® and BIO-Europe Spring®.

BioForward is a full-day event designed to be a practical, ‘one-stop-shop’ that provides leaders of growing Life Sciences companies with the knowledge, skills, connectivity, and services necessary to achieve sustainable commercial success.

BIOSPAIN is the largest biotech event organized by a national bioindustry association in Europe and one of the largest in the world by the number of one-to-one meetings (+3.300) and companies participating (+773). 34% of our delegates came from outside of Spain. Since 1999, the Spanish Bioindustry Association (AseBio) worked to achieve positive political and economic changes that promote and boost the development of the Spanish biotechnology industry. In order to do this, AseBio works closely with regional, national and European legislative bodies, as well as with all those social organisations that are committed to using biotechnology to improve citizens’ quality of life, environmental sustainability, economic development and skilled job creation.

The HealthTech Innovation Days demonstrates that access to innovative care for all depends on the right funding and partnership in-between actors in health and finance. This event organized by HealthTech For Care, an endowment fund launched by France Biotech, and co-organised with EIT Health, and in collaboration with BIO Deutschland, BioWin , CEBR, Flanders.bio,LifeSci , Irefi, Assobiotec, P-Bio, SwissBiotech & Sweden Bio will accelerate patient access to healthcare solutions and contribute to building a stronger ecosystem. This event is open to many attendees of the healthcare ecosystem.

The main programme for the 8th Annual HTIF is spread throughout 2 days (5th-6th of October) and will include HealthTech Innovation Day, focusing on Investment & Partnership in MedTech and Digital Health, and Managing Covid-19 Pandemic & Future Global Threats Day, which will include keynotes covering global supply chain and diagnostics. The two days will feature more than 12 hours of high-level speeches, panel discussions and spotlight showcases by leading industry corporates. In addition, there is a global company showcase of 25+ presentations by established public, private, emerging and seed companies, offering innovative solutions and are seeking investment and partnering opportunities. We anticipate 300+ delegates drawn from Digital Health, MedTech/Device companies, banks, investors and advisors.

BioFuture is a new two-day life science summit that features 80 company presentations, plenary sessions, workshops, and one-to-one partnering with over 550 attendees, including biopharma, life science, digital medicine, and key advisors. For a $200 discount apply the code BGBF200 at the registration.

Back for its 21st Annual Edition, this global bio-pharma industry event will address through its programme the main challenges for 2021 in investment, partnering and alliance management and prospects for 2022. Key players contribute their insights in panels which cover the macro picture as well as innovation in different therapeutic sectors. This highly transactional event draws together an exciting cross-section of early-stage/pre-IPO, late-stage and public companies with leading investors, analysts, money managers and pharma licensing executives. Supported and designed by leading figures within Europe’s pharmaceutical and biotech industry, this event will once again be covered by our regular media partners. The main programme for the 21st Annual BEF is spread throughout 2 days (7th-8th of October) and will include BioCapital & Investment Day and Bio-Pharma Partnering & Therapeutics Day. The two days will feature more than 15 hours of high-level speeches, panel discussions and spotlight showcases by leading industry corporates. In addition, there is a global company showcase of 50+ presentations by established public, private, emerging and seed companies, offering innovative solutions and seeking investment and partnering opportunities. This will include a limited number of Spotlight presentations, which will be delivered live as part of the main programme, other presentations will be added under company showcases and will be available on demand. We anticipate 650+ delegates will register for the forum from all Life Sciences sectors, with the target audience being corporate and financial investors/partners, bankers and advisors. ​Meetings will take place from the 4th to 8th of October. Moreover, the system will be open for 12 hours a day and we expect 1500+ meetings completed over 5 days. The conference will be held in Central European Time Zone.

BIO-Europe® event is the largest biotechnology partnering conference held in Europe. Over 4,000 global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships. Business development executives and dealmakers consider BIO-Europe a must-attend event and an effective business strategy enabling them to meet and present to numerous potential partners. BIO-Europe features the industry’s most advanced web-based partnering system enabling delegates from all parts of the biotechnology value chain to quickly identify, engage and enter into strategic relationships that drive their business successfully forward. BIO-Europe's world-class workshops, panels and active exhibition along with thousands of prescheduled one-to-one meetings make this event an unrivaled forum for companies across the biotech value chain to meet and do business.

Understand the valuation concepts and techniques that are commonly applied in the pharma and biotech world – Know how to assess and calculate the value of a biotech company – Learn how to calculate the value of a pharmaceutical in development and how to structure a licensing deal.

The GIANT (Global Innovation and New Technology) Health Event is an unmissable innovation festival with over 25 conferences, 450 speakers, immersive workshops, and Beanstalks (a global startup competition for prizes). Our vision is to improve the health and well-being of people around the world, by promoting healthcare innovation and supporting health-tech entrepreneurs. In 2021, we will be holding two events aimed at creating opportunities to connect people who would not have crossed paths otherwise.

With the highest attending rate of academics, TTOs and research institutions, BioFIT is the place where academia-industry collaborations get started. BioFIT has taken on a whole new dimension becoming the meeting point in Europe for tech transfer and for sourcing early-stage innovations stemming from public research institutions, academic spin-offs and emerging biotech companies. Together with big pharma, biotech and diagnostic companies, BioFIT operates as a platform to build partnerships for all public and private actors. BioFIT is also the European marketplace for pre-seed, seed and Series A investment in Life Sciences.

With 700 international participants from 25+ countries, MedFIT is your opportunity to connect with international key innovators in the MedTech, diagnostic and digital health sectors. As a leading European partnering event, MedFIT provides the ideal environment to help industry players to source early-stage assets, to facilitate the emergence of collaborative projects between big players, public research institutions, start-ups and SMEs, to increase licensing opportunities, to obtain funding and to facilitate market access.

BIOHK2021 is an international convention organized by HKBIO that aims to provide a global platform for exploring the potential and limitless biotech opportunities sprouting in Hong Kong and allow networking between leading industry practitioners from around the globe. BIOHK2021 is comprised of three events - the Expo, Conference & Roadshow, and One2One Partnering. All three will be held simultaneously over a period of 4 days in Hong Kong.